The global RNA Analysis & Transcriptomic market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Thereport includes an overview of the development of the RNA Analysis & Transcriptomic industry chain, the market status of Clinical Diagnostics (Microarrays, Sequencing), Drug Discovery (Microarrays, Sequencing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of RNA Analysis & Transcriptomic.
Regionally, the report analyzes the RNA Analysis & Transcriptomic markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global RNA Analysis & Transcriptomic market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the RNA Analysis & Transcriptomic market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the RNA Analysis & Transcriptomic industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Microarrays, Sequencing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the RNA Analysis & Transcriptomic market.
Regional Analysis: The report involves examining the RNA Analysis & Transcriptomic market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the RNA Analysis & Transcriptomic market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to RNA Analysis & Transcriptomic:
Company Analysis: Report covers individual RNA Analysis & Transcriptomic players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards RNA Analysis & Transcriptomic This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical Diagnostics, Drug Discovery).
Technology Analysis: Report covers specific technologies relevant to RNA Analysis & Transcriptomic. It assesses the current state, advancements, and potential future developments in RNA Analysis & Transcriptomic areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the RNA Analysis & Transcriptomic market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
RNA Analysis & Transcriptomic market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Microarrays
Sequencing
Polymerase Chain Reaction
RNA Interference
Market segment by Application
Clinical Diagnostics
Drug Discovery
Toxicogenomics
Comparative Transcriptomics
Market segment by players, this report covers
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Merck KGaA
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech SL
Acobiom
GenXPro GmbH
CD Genomics
Promega Corporation
Cenix BioScience GmbH
Takara Holdings, Inc.
bioM茅rieux SA
LC Sciences LLC
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe RNA Analysis & Transcriptomic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of RNA Analysis & Transcriptomic, with revenue, gross margin and global market share of RNA Analysis & Transcriptomic from 2019 to 2024.
Chapter 3, the RNA Analysis & Transcriptomic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and RNA Analysis & Transcriptomic market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of RNA Analysis & Transcriptomic.
Chapter 13, to describe RNA Analysis & Transcriptomic research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of RNA Analysis & Transcriptomic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of RNA Analysis & Transcriptomic by Type
1.3.1 Overview: Global RNA Analysis & Transcriptomic Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global RNA Analysis & Transcriptomic Consumption Value Market Share by Type in 2023
1.3.3 Microarrays
1.3.4 Sequencing
1.3.5 Polymerase Chain Reaction
1.3.6 RNA Interference
1.4 Global RNA Analysis & Transcriptomic Market by Application
1.4.1 Overview: Global RNA Analysis & Transcriptomic Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Clinical Diagnostics
1.4.3 Drug Discovery
1.4.4 Toxicogenomics
1.4.5 Comparative Transcriptomics
1.5 Global RNA Analysis & Transcriptomic Market Size & Forecast
1.6 Global RNA Analysis & Transcriptomic Market Size and Forecast by Region
1.6.1 Global RNA Analysis & Transcriptomic Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global RNA Analysis & Transcriptomic Market Size by Region, (2019-2030)
1.6.3 North America RNA Analysis & Transcriptomic Market Size and Prospect (2019-2030)
1.6.4 Europe RNA Analysis & Transcriptomic Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific RNA Analysis & Transcriptomic Market Size and Prospect (2019-2030)
1.6.6 South America RNA Analysis & Transcriptomic Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa RNA Analysis & Transcriptomic Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Thermo Fisher Scientific, Inc.
2.1.1 Thermo Fisher Scientific, Inc. Details
2.1.2 Thermo Fisher Scientific, Inc. Major Business
2.1.3 Thermo Fisher Scientific, Inc. RNA Analysis & Transcriptomic Product and Solutions
2.1.4 Thermo Fisher Scientific, Inc. RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.2 Bio-Rad Laboratories, Inc.
2.2.1 Bio-Rad Laboratories, Inc. Details
2.2.2 Bio-Rad Laboratories, Inc. Major Business
2.2.3 Bio-Rad Laboratories, Inc. RNA Analysis & Transcriptomic Product and Solutions
2.2.4 Bio-Rad Laboratories, Inc. RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bio-Rad Laboratories, Inc. Recent Developments and Future Plans
2.3 Merck KGaA
2.3.1 Merck KGaA Details
2.3.2 Merck KGaA Major Business
2.3.3 Merck KGaA RNA Analysis & Transcriptomic Product and Solutions
2.3.4 Merck KGaA RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Merck KGaA Recent Developments and Future Plans
2.4 Agilent Technologies, Inc.
2.4.1 Agilent Technologies, Inc. Details
2.4.2 Agilent Technologies, Inc. Major Business
2.4.3 Agilent Technologies, Inc. RNA Analysis & Transcriptomic Product and Solutions
2.4.4 Agilent Technologies, Inc. RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.5 F. Hoffmann-La Roche Ltd.
2.5.1 F. Hoffmann-La Roche Ltd. Details
2.5.2 F. Hoffmann-La Roche Ltd. Major Business
2.5.3 F. Hoffmann-La Roche Ltd. RNA Analysis & Transcriptomic Product and Solutions
2.5.4 F. Hoffmann-La Roche Ltd. RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 F. Hoffmann-La Roche Ltd. Recent Developments and Future Plans
2.6 Danaher Corporation
2.6.1 Danaher Corporation Details
2.6.2 Danaher Corporation Major Business
2.6.3 Danaher Corporation RNA Analysis & Transcriptomic Product and Solutions
2.6.4 Danaher Corporation RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Danaher Corporation Recent Developments and Future Plans
2.7 Fluidigm Corporation
2.7.1 Fluidigm Corporation Details
2.7.2 Fluidigm Corporation Major Business
2.7.3 Fluidigm Corporation RNA Analysis & Transcriptomic Product and Solutions
2.7.4 Fluidigm Corporation RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Fluidigm Corporation Recent Developments and Future Plans
2.8 Eurofins Scientific
2.8.1 Eurofins Scientific Details
2.8.2 Eurofins Scientific Major Business
2.8.3 Eurofins Scientific RNA Analysis & Transcriptomic Product and Solutions
2.8.4 Eurofins Scientific RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Eurofins Scientific Recent Developments and Future Plans
2.9 Sequentia Biotech SL
2.9.1 Sequentia Biotech SL Details
2.9.2 Sequentia Biotech SL Major Business
2.9.3 Sequentia Biotech SL RNA Analysis & Transcriptomic Product and Solutions
2.9.4 Sequentia Biotech SL RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Sequentia Biotech SL Recent Developments and Future Plans
2.10 Acobiom
2.10.1 Acobiom Details
2.10.2 Acobiom Major Business
2.10.3 Acobiom RNA Analysis & Transcriptomic Product and Solutions
2.10.4 Acobiom RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Acobiom Recent Developments and Future Plans
2.11 GenXPro GmbH
2.11.1 GenXPro GmbH Details
2.11.2 GenXPro GmbH Major Business
2.11.3 GenXPro GmbH RNA Analysis & Transcriptomic Product and Solutions
2.11.4 GenXPro GmbH RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 GenXPro GmbH Recent Developments and Future Plans
2.12 CD Genomics
2.12.1 CD Genomics Details
2.12.2 CD Genomics Major Business
2.12.3 CD Genomics RNA Analysis & Transcriptomic Product and Solutions
2.12.4 CD Genomics RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 CD Genomics Recent Developments and Future Plans
2.13 Promega Corporation
2.13.1 Promega Corporation Details
2.13.2 Promega Corporation Major Business
2.13.3 Promega Corporation RNA Analysis & Transcriptomic Product and Solutions
2.13.4 Promega Corporation RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Promega Corporation Recent Developments and Future Plans
2.14 Cenix BioScience GmbH
2.14.1 Cenix BioScience GmbH Details
2.14.2 Cenix BioScience GmbH Major Business
2.14.3 Cenix BioScience GmbH RNA Analysis & Transcriptomic Product and Solutions
2.14.4 Cenix BioScience GmbH RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Cenix BioScience GmbH Recent Developments and Future Plans
2.15 Takara Holdings, Inc.
2.15.1 Takara Holdings, Inc. Details
2.15.2 Takara Holdings, Inc. Major Business
2.15.3 Takara Holdings, Inc. RNA Analysis & Transcriptomic Product and Solutions
2.15.4 Takara Holdings, Inc. RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Takara Holdings, Inc. Recent Developments and Future Plans
2.16 bioM茅rieux SA
2.16.1 bioM茅rieux SA Details
2.16.2 bioM茅rieux SA Major Business
2.16.3 bioM茅rieux SA RNA Analysis & Transcriptomic Product and Solutions
2.16.4 bioM茅rieux SA RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 bioM茅rieux SA Recent Developments and Future Plans
2.17 LC Sciences LLC
2.17.1 LC Sciences LLC Details
2.17.2 LC Sciences LLC Major Business
2.17.3 LC Sciences LLC RNA Analysis & Transcriptomic Product and Solutions
2.17.4 LC Sciences LLC RNA Analysis & Transcriptomic Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 LC Sciences LLC Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global RNA Analysis & Transcriptomic Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of RNA Analysis & Transcriptomic by Company Revenue
3.2.2 Top 3 RNA Analysis & Transcriptomic Players Market Share in 2023
3.2.3 Top 6 RNA Analysis & Transcriptomic Players Market Share in 2023
3.3 RNA Analysis & Transcriptomic Market: Overall Company Footprint Analysis
3.3.1 RNA Analysis & Transcriptomic Market: Region Footprint
3.3.2 RNA Analysis & Transcriptomic Market: Company Product Type Footprint
3.3.3 RNA Analysis & Transcriptomic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global RNA Analysis & Transcriptomic Consumption Value and Market Share by Type (2019-2024)
4.2 Global RNA Analysis & Transcriptomic Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global RNA Analysis & Transcriptomic Consumption Value Market Share by Application (2019-2024)
5.2 Global RNA Analysis & Transcriptomic Market Forecast by Application (2025-2030)
6 North America
6.1 North America RNA Analysis & Transcriptomic Consumption Value by Type (2019-2030)
6.2 North America RNA Analysis & Transcriptomic Consumption Value by Application (2019-2030)
6.3 North America RNA Analysis & Transcriptomic Market Size by Country
6.3.1 North America RNA Analysis & Transcriptomic Consumption Value by Country (2019-2030)
6.3.2 United States RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
6.3.3 Canada RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
6.3.4 Mexico RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe RNA Analysis & Transcriptomic Consumption Value by Type (2019-2030)
7.2 Europe RNA Analysis & Transcriptomic Consumption Value by Application (2019-2030)
7.3 Europe RNA Analysis & Transcriptomic Market Size by Country
7.3.1 Europe RNA Analysis & Transcriptomic Consumption Value by Country (2019-2030)
7.3.2 Germany RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
7.3.3 France RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
7.3.4 United Kingdom RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
7.3.5 Russia RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
7.3.6 Italy RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific RNA Analysis & Transcriptomic Consumption Value by Type (2019-2030)
8.2 Asia-Pacific RNA Analysis & Transcriptomic Consumption Value by Application (2019-2030)
8.3 Asia-Pacific RNA Analysis & Transcriptomic Market Size by Region
8.3.1 Asia-Pacific RNA Analysis & Transcriptomic Consumption Value by Region (2019-2030)
8.3.2 China RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
8.3.3 Japan RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
8.3.4 South Korea RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
8.3.5 India RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
8.3.7 Australia RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
9 South America
9.1 South America RNA Analysis & Transcriptomic Consumption Value by Type (2019-2030)
9.2 South America RNA Analysis & Transcriptomic Consumption Value by Application (2019-2030)
9.3 South America RNA Analysis & Transcriptomic Market Size by Country
9.3.1 South America RNA Analysis & Transcriptomic Consumption Value by Country (2019-2030)
9.3.2 Brazil RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
9.3.3 Argentina RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa RNA Analysis & Transcriptomic Consumption Value by Type (2019-2030)
10.2 Middle East & Africa RNA Analysis & Transcriptomic Consumption Value by Application (2019-2030)
10.3 Middle East & Africa RNA Analysis & Transcriptomic Market Size by Country
10.3.1 Middle East & Africa RNA Analysis & Transcriptomic Consumption Value by Country (2019-2030)
10.3.2 Turkey RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
10.3.4 UAE RNA Analysis & Transcriptomic Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 RNA Analysis & Transcriptomic Market Drivers
11.2 RNA Analysis & Transcriptomic Market Restraints
11.3 RNA Analysis & Transcriptomic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 RNA Analysis & Transcriptomic Industry Chain
12.2 RNA Analysis & Transcriptomic Upstream Analysis
12.3 RNA Analysis & Transcriptomic Midstream Analysis
12.4 RNA Analysis & Transcriptomic Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Merck KGaA
Agilent Technologies, Inc.
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Fluidigm Corporation
Eurofins Scientific
Sequentia Biotech SL
Acobiom
GenXPro GmbH
CD Genomics
Promega Corporation
Cenix BioScience GmbH
Takara Holdings, Inc.
bioM茅rieux SA
LC Sciences LLC
听
听
*If Applicable.